A detailed history of Paradigm Financial Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Paradigm Financial Partners, LLC holds 7,714 shares of VRTX stock, worth $3.58 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
7,714
Previous 8,121 5.01%
Holding current value
$3.58 Million
Previous $3.81 Million 5.75%
% of portfolio
0.51%
Previous 0.58%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$460.0 - $505.78 $187,220 - $205,852
-407 Reduced 5.01%
7,714 $3.59 Million
Q2 2024

Aug 13, 2024

BUY
$392.81 - $485.53 $502,796 - $621,478
1,280 Added 18.71%
8,121 $3.81 Million
Q1 2024

May 15, 2024

BUY
$407.69 - $446.08 $792,957 - $867,625
1,945 Added 39.73%
6,841 $2.86 Million
Q4 2023

Feb 05, 2024

BUY
$343.0 - $410.68 $1.17 Million - $1.4 Million
3,399 Added 227.05%
4,896 $1.99 Million
Q3 2023

Oct 12, 2023

BUY
$338.18 - $362.46 $17,247 - $18,485
51 Added 3.53%
1,497 $520,000
Q2 2023

Jul 13, 2023

BUY
$314.42 - $351.91 $9,432 - $10,557
30 Added 2.12%
1,446 $508,000
Q1 2023

Apr 11, 2023

BUY
$283.23 - $323.1 $401,053 - $457,509
1,416 New
1,416 $446,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Paradigm Financial Partners, LLC Portfolio

Follow Paradigm Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Financial Partners, LLC with notifications on news.